Sensitivity to First-Line Chemotherapy for Metastatic Breast Cancer in BRCA1 and BRCA2 Mutation Carriers

M. Kriege, C. Seynaeve, E.J. Heijboer, J.M. Collee, M.B.E. Menke-Pluymers, C.C.M. Bartels, M.M. Tilanus-Linthorst, J. Blom, E. Huijskens, A. Jager, A.M.W. van den Ouweland, B. van Geel, M.J. Hooning, C.T. Brekelmans, JG Klijn

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)3764-3771
JournalJournal of Clinical Oncology
Volume27
Issue number23
DOIs
Publication statusPublished - 2009

Cite this

Kriege, M., Seynaeve, C., Heijboer, E. J., Collee, J. M., Menke-Pluymers, M. B. E., Bartels, C. C. M., ... Klijn, JG. (2009). Sensitivity to First-Line Chemotherapy for Metastatic Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. Journal of Clinical Oncology, 27(23), 3764-3771. https://doi.org/10.1200/JCO.2008.19.9067